Viewing Study NCT06756932


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-01-04 @ 12:19 PM
Study NCT ID: NCT06756932
Status: RECRUITING
Last Update Posted: 2025-11-10
First Post: 2024-12-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
Sponsor: BeOne Medicines
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module